In Neurology Today, Dr. Steven DeKosky weighed in on a new meta-analysis showing that levels of phosphorylated tau 217 accurately predicted the presence of amyloid in the cortex of participants.
Dr. Steven DeKosky co-authored study in JAMA Neurology showing link between two diabetes drug classes and lower Alzheimer's risk in Type 2 diabetes patients.
UF neurologist Dr. Steven T. DeKosky honored for work to bolster global Alzheimer’s research network
MBI deputy director Dr. Steven DeKosky commented for article in Neurology Today.
In The Conversation, UF neuroscientist Dr. Steven DeKosky explains new discoveries with treatment implications.
Drs. Steven DeKosky and Glenn Smith discuss Lecanemab for WUFT article.
Dr. Steven DeKosky has been cited over 100K times, per Google Scholar.
Dr. Steven DeKosky provides indicators to help “guestimate” rate of cognitive decline.
Conversation article co-authored by Drs. Steven DeKosky and Michael Jaffee discusses new research about dementia and COVID-19 risk.
View a recording of Drs. Todd Golde and Steven DeKosky’s UF Health Webinar.
